The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry.

Nishaanth DalavayeSimon ErridgeMartha NicholasManaswini PillaiLara BapirCarl HolveyRoss CoomberJames J RuckerJonathan HoareMikael Hans Sodergren

Published in: Expert review of gastroenterology & hepatology (2022)

Patients treated with CBMPs for refractory symptoms of Crohn's disease and ulcerative colitis demonstrated a short-term improvement in IBD-specific and general HRQoL. Prior cannabis consumers reported greater improvement compared to cannabis-naïve individuals.

Keyphrases

ulcerative colitis
healthcare
cross sectional
depressive symptoms
data analysis